Table 2—

HRs and 95% CIs for the incident diabetes and incident NF-CVD groups for total, CVD, and CHD mortality (mortality follow-up through 1999)

Unadjusted
Multivariate adjusted*
HR (95% CI)PHR (95% CI)P
Total mortality
 With diabetes vs. neither diabetes nor NF-CVD1.62 (1.47–1.78)<0.00011.49 (1.34–1.64)<0.0001
 With NF-CVD vs. neither diabetes nor NF-CVD2.12 (1.90–2.37)<0.00011.92 (1.71–2.15)<0.0001
 With diabetes and NF-CVD vs. neither diabetes nor NF-CVD3.34 (2.70–4.13)<0.00012.75 (2.22–3.42)<0.0001
 With NF-CVD vs. with diabetes1.31 (1.14–1.51)0.00011.29 (1.12–1.49)0.0004
CVD mortality
 With diabetes vs. neither diabetes nor NF-CVD1.77 (1.54–2.03)<0.00011.51 (1.31–1.75)<0.0001
 With NF-CVD vs. neither diabetes nor NF-CVD3.13 (2.72–3.60)<0.00012.66 (2.30–3.07)<0.0001
 With diabetes and NF-CVD vs. neither diabetes nor NF-CVD4.50 (3.41–5.93)<0.00013.45 (2.60–4.58)<0.0001
 With NF-CVD vs. with diabetes1.77 (1.48–2.12)<0.00011.76 (1.45–2.12)<0.0001
CHD mortality
 With diabetes vs. neither diabetes nor NF-CVD1.85 (1.57–2.18)<0.00011.62 (1.36–1.93)<0.0001
 With NF-CVD vs. neither diabetes nor NF-CVD3.63 (3.09–4.27)<0.00013.05 (2.58–3.60)<0.0001
 With diabetes and NF-CVD vs. neither diabetes nor NF-CVD5.81 (4.31–7.83)<0.00014.56 (3.35–6.20)<0.0001
 With NF-CVD vs. with diabetes1.96 (1.59–2.42)<0.00011.88 (1.51–2.34)<0.0001
  • *

    * Adjusted for special intervention/usual care, age, race, baseline and sixth annual visit smoking status, drinks per week, heart rate, heart rate-adjusted QT interval, height, parental diabetes, parental heart disease, proteinuria, BMI, SBP, uric acid, TGs, LDL cholesterol, HDL cholesterol, and thiazide use.